Neighborhood LTC Pharmacy Announces New Technology Partnership With Impruvon Health

August 2, 2024 12:00 PM

LINCOLN, NE / ACCESSWIRE / August 2, 2024 / Neighborhood LTC Pharmacy, a leader in pharmacy services for individuals with Intellectual and Developmental Disabilities (IDD), is thrilled to announce a new technology partnership with Impruvon Health. This collaboration introduces new options to Neighborhood LTC Pharmacy customers, including technology aimed at enhancing the quality of life for individuals by promoting independence and improving...

Read more

Biden-Harris-DEA Marijuana Scam - MMJ's Legal Actions Proceed in Federal Court

August 2, 2024 11:15 AM

WASHINGTON, DC / ACCESSWIRE / August 2, 2024 / In recent social media posts, the Democratic National Committee (DNC) claimed that the Biden administration had "reclassified marijuana" and ended the "failed approach to marijuana," symbolized with green checkmark emojis.However, Tim Moynahan, lawyer and chairman of MMJ BioPharma Cultivation, criticized these claims, emphasizing that actions are more significant than words. MMJ BioPharma...

Read more

Partners Cooperative Selects Curvo for Digital Transformation

August 2, 2024 10:30 AM

EVANSVILLE, IN / ACCESSWIRE / August 2, 2024 / In a major step towards greater cost efficiency and operational effectiveness, Partners Cooperative has signed a five-year agreement with healthcare supply chain technology leader Curvo.Partners Cooperative Selects Curvo for Digital Transformation As a non-profit, shared-services cooperative, Partners manages a portfolio of hundreds of contracts, and members work together to improve costs in a...

Read more

Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Illinois Chicago College of Pharmacy

August 2, 2024 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 2, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that Elaine Elisabetsky, PhD, is conducting a talk on Friday, August 2, 2024 from 12:30 PM - 2:00 PM Central covering several decades of research on plant-based medicines used to manage schizophrenia. Dr. Elisabetsky's talk is part of the annual Norman R. Farnsworth Lecture series at the University of Illinois Chicago (UIC) College of...

Read more

Humworld's Cutting-Edge, Cost-Effective Healthcare Software: Humhealth

August 2, 2024 10:00 AM

WIXOM, MI / ACCESSWIRE / August 2, 2024 / Humhealth by Humworld was developed based on the principle that quality should never be sacrificed to attain affordability. Humhealth provides an all-encompassing software solution tailored for chronic care management and remote patient monitoring, ensuring that patients receive optimal care at every stage of their health journey. Designed with user-friendliness in mind, our software not only simplifies...

Read more

Utah Medical Products, Inc. Announces Quarterly Dividend

August 2, 2024 10:00 AM

SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on October 4, 2024 to stockholders of record at the close of business on September 20, 2024. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.Utah Medical Products, Inc., with particular...

Read more

America's Leading Online Chronic Care Management Educational Program: Hyalite Care Academy

August 2, 2024 8:30 AM

Hyalite Care Academy offers two new courses: The Essentials of CCM and The Business of CCMBOZEMAN, MT / ACCESSWIRE / August 2, 2024 / Despite the high demand for Chronic Care Management (CCM) services for clinics across America, high-quality educational opportunities teaching this skill set have been severely limited. The dearth of know-how for entrepreneurial registered nurses and other healthcare professionals pursuing this profession...

Read more

Chronic Prostatitis or Pelvic Pain Syndrome Treatment with Dr Allen's Device Safely Prevents Prostate Enlargement (BPH)

August 2, 2024 3:00 AM

Medical innovation discussions held during the latest LSX World Congress in London highlighted the necessity of adopting more out-of-hospital treatments, such as Thermobalancing therapy, increasing patient safety. New clinical research has confirmed high effectiveness and total safety of Thermobalancing therapy and wearable Dr Allen's Devices in relieving pain in patients with chronic prostatitis. More importantly, this non-surgical treatment...

Read more

Mothers' Milk Bank California Launches Cares Program and Marks 50 Years of Service

August 1, 2024 11:45 AM

SAN JOSE, CA / ACCESSWIRE / August 1, 2024 / Mothers' Milk Bank California (MMB California), the oldest continuously operating independent nonprofit milk bank in the United States, celebrates a significant milestone of half a century dedicated to serving infants and families in need across the country.MMB has updated the name of the organization to include 'California' to honor its roots in the state. Central to MMB California's legacy is a...

Read more

Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

August 1, 2024 11:15 AM

AUSTIN, TX / ACCESSWIRE / August 1, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, will hold a business update conference call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time in conjunction with its reported financial results for the second quarter ended June 30, 2024 and to discuss key milestones....

Read more

Zoelife Psychiatric Services Receives Prestigious Accreditation for Outpatient Treatment for Adults, Children and Adolescents

August 1, 2024 10:00 AM

FRANKFORT, IL / ACCESSWIRE / August 1, 2024 / Zoelife Psychiatric Services is proud to announce that it has earned a prestigious Three-Year Accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF) for its Outpatient treatment mental health programs for Adults, Children, and Adolescents located in Frankfort and Cresthill, Illinois. This esteemed recognition represents the highest level of accreditation that CARF can...

Read more

Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year

August 1, 2024 10:00 AM

Quest Diagnostics (NYSE:DGX), a leading provider of diagnostic information services, announced it has been named to the 2024 Disability Equality Index® Best Places to Work for Disability Inclusion by Disability: IN and the American Association of People with Disabilities (AAPD).The announcement marks the seventh consecutive year that Quest has been recognized by the Disability Equality Index®. The company achieved a top score of 100, improving...

Read more

1upHealth Launches Customer Advisory Board to Advance Industry-Wide Interoperability and Fuel Technological Innovation

August 1, 2024 9:03 AM

1upHealth, the leading health data management platform provider for claims and clinical data interoperability, today announced it has formed a Customer Advisory Board (CAB) to leverage the unique expertise of its client base and drive company and industry innovation. The CAB showcases a broad collective of executives from leading health plans such as CVS/Aetna, Mass General Brigham Health Plan, AIDS Healthcare Foundation (AHF), Cigna Healthcare,...

Read more

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health's Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

August 1, 2024 9:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 1, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") family company Napo Pharmaceuticals ("Napo") today announced that the results of two independent investigator-initiated studies of crofelemer, Napo's novel, plant-based oral prescription drug, showed a benefit in patients with chronic refractory diarrhea and have been accepted for poster presentations at the American College of Gastroenterology Annual...

Read more

Animal Surgical Center Proudly Announces AAHA Accreditation: Leading the Way in Veterinary Excellence

August 1, 2024 9:00 AM

Animal Surgical Center Earns Coveted AAHA Accreditation, Demonstrating Unwavering Commitment to Excellence in Veterinary CareOCEANSIDE, NY / ACCESSWIRE / August 1, 2024 / Animal Surgical Center, a premier multi-disciplinary veterinary practice located in Oceanside, New York, is thrilled to announce that they have achieved accreditation from the prestigious American Animal Hospital Association (AAHA). This accolade places them among only 15% of...

Read more

Village Savings and Loan Associations, With Kal Lakew and Emily Janoch

August 1, 2024 8:15 AM

Podcast Interview exploring the balance between designing for evidence and building for adaptation.NORTHAMPTON, MA / ACCESSWIRE / August 1, 2024 / CAREOriginally published on Business Fights PovertyWhat are Village Savings and Loan Associations (VSLAs) and why can they be transformative for communities, particularly for women? Social Impact Pioneers Kalkidan (Kal) Lakew and Emily Janoch from the international NGO, CARE, explore how VSLAs...

Read more

CBD Life Sciences, Inc. (CBDL) Signs MOU With Large Mushroom Supplement Company

August 1, 2024 8:00 AM

SCOTTSDALE, AZ / ACCESSWIRE / August 1, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, has announced that it's signed a MOU (Memorandum of understanding) with a mushroom supplement company. This company will work hand in hand with our vision as were able to expand our revenue opportunities into not only the CBD space but the mushroom space as...

Read more

RETRANSMISSION: Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports

August 1, 2024 8:00 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced publication of preclinical and phase 1 clinical data on JNJ-2113 in the journal Scientific Reports, a Nature publication and the 5th most-cited journal in the world, according to the publisher. A link to the publication can be found HERE.JNJ-2113 is the first- and only-in-class targeted oral peptide inhibitor of the IL-23 receptor in clinical development. Based on...

Read more

FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate

August 1, 2024 7:45 AM

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.CHATHAM, NJ...

Read more

Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports

August 1, 2024 7:00 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced publication of preclinical and phase 1 clinical data on JNJ-2113 in the journal Scientific Reports, a Nature publication and the 5th most-cited journal in the world, according to the publisher. A link to the publication can be found HERE.JNJ-2113 is the first- and only-in-class targeted oral peptide inhibitor of the IL-23 receptor in clinical development. Based on...

Read more